* Cardlytics Inc CDLX.OQ CDLX.O is expected to show a
fall in
quarterly revenue when it reports results on August 1.
* The Atlanta Georgia-based company is expected to report
a
8.4% decrease in revenue to $69.071 million from $75.41 million
a year ago, according to the mean estimate from 3 analysts,
based on Refinitiv data. The company's guidance on May 4 2023,
for the period ended June 30, was for revenue between $65.00
million and $74.00 million.
* Refinitiv's mean analyst estimate for Cardlytics Inc is
for a
loss of 35 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts had risen by
about 6.3%
in the last three months.
* Wall Street's median 12-month price target for Cardlytics
Inc is
$9, below its last closing price of $11.01.
The company's guidance on May 4 2023 for the period ended June
30 was for Earnings before Interest, Taxes, Depreciation and
Amortization of between 65 million and -6 million (USD).
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Mar. 31 2023 -0.56 -0.56 -0.25 Beat 55.7
Dec. 31 2023 -0.46 -0.46 -0.29 Beat 37.5
Sep. 30 2022 -0.50 -0.57 -0.50 Beat 12.3
Jun. 30 2022 -0.42 -0.47 -0.65 Missed -38.9
Mar. -0.52 -0.55 -0.38 Beat 31.3
31 2022
Dec. 31 2021 -0.36 -0.42 -0.15 Beat 63.9
Sep. 30 2021 -0.52 -0.54 -0.33 Beat 38.9
Jun. 30 2021 -0.38 -0.39 -0.39 Met -0.9
This summary was machine generated July 29 at 02:02 GMT. All
figures in US dollars unless otherwise stated